Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?

Buchanan RW, Keefe RSE, Umbricht D, Green MF, Laughren T, Marder SR
Schizophr Bull. 2011 Nov; 37(6):1209-17. PMID: 20410237. Pubmed